Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2021

Open Access 01-12-2021 | Colon Cancer | Research

Identification of a ferroptosis-related gene signature predictive model in colon cancer

Authors: Ye Wang, Heng-bo Xia, Zhang-ming Chen, Lei Meng, A-man Xu

Published in: World Journal of Surgical Oncology | Issue 1/2021

Login to get access

Abstract

Background

The prognosis of colon cancer (CC) is challenging to predict due to its highly heterogeneous nature. Ferroptosis, an iron-dependent form of cell death, has roles in various cancers; however, the correlation between ferroptosis-related genes (FRGs) and prognosis in CC remains unclear.

Methods

The expression profiles of FRGs and relevant clinical information were retrieved from the Cancer Genome Atlas (TCGA) database. Cox regression analysis and the least absolute shrinkage and selection operator (LASSO) regression model were performed to build a prognostic model in TCGA cohort.

Results

Ten FRGs, five of which had mutation rates ≥ 3%, were found to be related to the overall survival (OS) of patients with CC. Patients were divided into high- and low-risk groups based on the results of Cox regression and LASSO analysis. Patients in the low-risk group had a significantly longer survival time than patients in the high-risk group (P < 0.001). Enrichment analyses in different risk groups showed that the altered genes were associated with the extracellular matrix, fatty acid metabolism, and peroxisome. Age, risk score, T stage, N stage, and M stage were independent predictors of patient OS based on the results of Cox analysis. Finally, a nomogram was constructed to predict 1-, 3-, and 5-year OS of patients with CC based on the above five independent factors.

Conclusion

A novel FRG model can be used for prognostic prediction in CC and may be helpful for individualized treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin D, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. 2019;144(8):1941-53. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin D, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. 2019;144(8):1941-53.
2.
go back to reference Bhandari A, Woodhouse M, Gupta SJJoimtopotAFfCR. Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: a SEER-based analysis with comparison to other young-onset cancers. 2017;65(2):311-5. Bhandari A, Woodhouse M, Gupta SJJoimtopotAFfCR. Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: a SEER-based analysis with comparison to other young-onset cancers. 2017;65(2):311-5.
3.
go back to reference Schmoll H, Van Cutsem E, Stein A, Valentini V, Glimelius B. Haustermans K, et al. ESMO Consensus guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. 2012;23(10):2479–516. Schmoll H, Van Cutsem E, Stein A, Valentini V, Glimelius B. Haustermans K, et al. ESMO Consensus guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. 2012;23(10):2479–516.
4.
go back to reference JN. Comprehensive molecular characterization of human colon and rectal cancer. 2012;487(7407):330-7. JN. Comprehensive molecular characterization of human colon and rectal cancer. 2012;487(7407):330-7.
5.
go back to reference Guo X, Lin W, Wen W, Huyghe J, Bien S, Cai Q, et al. Identifying novel susceptibility genes for colorectal cancer risk from a transcriptome-wide association study of 125,478 subjects. 2020. Guo X, Lin W, Wen W, Huyghe J, Bien S, Cai Q, et al. Identifying novel susceptibility genes for colorectal cancer risk from a transcriptome-wide association study of 125,478 subjects. 2020.
6.
go back to reference Uhlen M, Zhang C, Lee S, Sjöstedt E, Fagerberg L, Bidkhori G, et al. A pathology atlas of the human cancer transcriptome. 2017;357(6352). Uhlen M, Zhang C, Lee S, Sjöstedt E, Fagerberg L, Bidkhori G, et al. A pathology atlas of the human cancer transcriptome. 2017;357(6352).
7.
go back to reference Tang D. Kroemer GJCbC. Ferroptosis. 2020;30(21):R1292–R7. Tang D. Kroemer GJCbC. Ferroptosis. 2020;30(21):R1292–R7.
8.
go back to reference Yang W, SriRamaratnam R, Welsch M, Shimada K, Skouta R. Viswanathan V, et al. Regulation of ferroptotic cancer cell death by GPX4. 2014;156:317–31. Yang W, SriRamaratnam R, Welsch M, Shimada K, Skouta R. Viswanathan V, et al. Regulation of ferroptotic cancer cell death by GPX4. 2014;156:317–31.
9.
go back to reference Liang C, Zhang X, Yang M. Dong XJAm. Recent progress in ferroptosis inducers for cancer therapy. 2019;31(51):e1904197. Liang C, Zhang X, Yang M. Dong XJAm. Recent progress in ferroptosis inducers for cancer therapy. 2019;31(51):e1904197.
10.
go back to reference Hassannia B, Vandenabeele P. Vanden Berghe TJCc. Targeting ferroptosis to iron out cancer. 2019;35(6):830–49. Hassannia B, Vandenabeele P. Vanden Berghe TJCc. Targeting ferroptosis to iron out cancer. 2019;35(6):830–49.
11.
go back to reference Jiang L, Kon N, Li T, Wang S, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. 2015;520(7545):57-62. Jiang L, Kon N, Li T, Wang S, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. 2015;520(7545):57-62.
12.
go back to reference Sharma P, Shimura T, Banwait J. Goel AJC. Andrographis-mediated chemosensitization through activation of ferroptosis and suppression of β-catenin/Wnt-signaling pathways in colorectal cancer. 2020;41(10):1385–94. Sharma P, Shimura T, Banwait J. Goel AJC. Andrographis-mediated chemosensitization through activation of ferroptosis and suppression of β-catenin/Wnt-signaling pathways in colorectal cancer. 2020;41(10):1385–94.
13.
go back to reference Bobo D, Robinson K, Islam J, Thurecht K. Corrie SJPr. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. 2016;33(10):2373–87. Bobo D, Robinson K, Islam J, Thurecht K. Corrie SJPr. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. 2016;33(10):2373–87.
14.
go back to reference Lu D, Yang Z, Xia Q, Gao S, Sun S. Luo X, et al. ACADSB regulates ferroptosis and affects the migration, invasion, and proliferation of colorectal cancer cells. 2020;44(11):2334–43. Lu D, Yang Z, Xia Q, Gao S, Sun S. Luo X, et al. ACADSB regulates ferroptosis and affects the migration, invasion, and proliferation of colorectal cancer cells. 2020;44(11):2334–43.
15.
go back to reference Xu X, Zhang X, Wei C, Zheng D, Lu X, Yang Y, et al. Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis. 2020;152:105450. Xu X, Zhang X, Wei C, Zheng D, Lu X, Yang Y, et al. Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis. 2020;152:105450.
16.
go back to reference Park S, Oh J, Kim M. Jin EJAc, systems. Bromelain effectively suppresses Kras-mutant colorectal cancer by stimulating ferroptosis. 2018;22(5):334–40. Park S, Oh J, Kim M. Jin EJAc, systems. Bromelain effectively suppresses Kras-mutant colorectal cancer by stimulating ferroptosis. 2018;22(5):334–40.
17.
go back to reference Zhou N. Bao JJDtjobd, curation. FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. 2020;2020. Zhou N. Bao JJDtjobd, curation. FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. 2020;2020.
18.
go back to reference Gao J, Aksoy B, Dogrusoz U, Dresdner G, Gross B, Sumer S, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. 2013;6(269):pl1. Gao J, Aksoy B, Dogrusoz U, Dresdner G, Gross B, Sumer S, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. 2013;6(269):pl1.
19.
go back to reference Ju C, Wyss R, Franklin J, Schneeweiss S. Häggström J, van der Laan MJSmimr. Collaborative-controlled LASSO for constructing propensity score-based estimators in high-dimensional data. 2019;28(4):1044–63. Ju C, Wyss R, Franklin J, Schneeweiss S. Häggström J, van der Laan MJSmimr. Collaborative-controlled LASSO for constructing propensity score-based estimators in high-dimensional data. 2019;28(4):1044–63.
20.
go back to reference Simon N, Friedman J, Hastie T. Tibshirani RJJoss. Regularization paths for Cox’s proportional hazards model via coordinate descent. 2011;39(5):1–13. Simon N, Friedman J, Hastie T. Tibshirani RJJoss. Regularization paths for Cox’s proportional hazards model via coordinate descent. 2011;39(5):1–13.
21.
go back to reference Park SJTJot, surgery c. Nomogram: an analogue tool to deliver digital knowledge. 2018;155(4):1793. Park SJTJot, surgery c. Nomogram: an analogue tool to deliver digital knowledge. 2018;155(4):1793.
22.
go back to reference Witten D. Tibshirani RJSmimr. Survival analysis with high-dimensional covariates. 2010;19(1):29–51. Witten D. Tibshirani RJSmimr. Survival analysis with high-dimensional covariates. 2010;19(1):29–51.
23.
go back to reference Goeman JJBjBZ. L1 penalized estimation in the Cox proportional hazards model. 2010;52(1):70-84. Goeman JJBjBZ. L1 penalized estimation in the Cox proportional hazards model. 2010;52(1):70-84.
24.
go back to reference Chen X, Xu S, Zhao C, Liu BJB, communications br. Role of TLR4/NADPH oxidase 4 pathway in promoting cell death through autophagy and ferroptosis during heart failure. 2019;516(1):37-43. Chen X, Xu S, Zhao C, Liu BJB, communications br. Role of TLR4/NADPH oxidase 4 pathway in promoting cell death through autophagy and ferroptosis during heart failure. 2019;516(1):37-43.
25.
go back to reference Akaike T, Ida T, Wei F, Nishida M, Kumagai Y. Alam M, et al. Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergetics. 2017;8(1):1177. Akaike T, Ida T, Wei F, Nishida M, Kumagai Y. Alam M, et al. Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergetics. 2017;8(1):1177.
26.
go back to reference Hayano M, Yang W, Corn C, Pagano N. Stockwell BJCd, differentiation. Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation. 2016;23(2):270–8. Hayano M, Yang W, Corn C, Pagano N. Stockwell BJCd, differentiation. Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation. 2016;23(2):270–8.
27.
go back to reference Chen D, Tavana O, Chu B, Erber L, Chen Y, Baer R, et al. NRF2 is a major target of ARF in p53-independent tumor suppression. 2017;68(1):224-32.e4. Chen D, Tavana O, Chu B, Erber L, Chen Y, Baer R, et al. NRF2 is a major target of ARF in p53-independent tumor suppression. 2017;68(1):224-32.e4.
28.
go back to reference Dolma S, Selvadurai H, Lan X, Lee L, Kushida M, Voisin V, et al. Inhibition of dopamine receptor D4 impedes autophagic flux, proliferation, and survival of glioblastoma stem cells. 2016;29(6):859-73. Dolma S, Selvadurai H, Lan X, Lee L, Kushida M, Voisin V, et al. Inhibition of dopamine receptor D4 impedes autophagic flux, proliferation, and survival of glioblastoma stem cells. 2016;29(6):859-73.
29.
go back to reference Wang X, Wang Z, Luo C, Mao X, Li X. Yin J, et al. The prospective value of dopamine receptors on bio-behavior of tumor. 2019;10(7):1622–32. Wang X, Wang Z, Luo C, Mao X, Li X. Yin J, et al. The prospective value of dopamine receptors on bio-behavior of tumor. 2019;10(7):1622–32.
30.
go back to reference Ishige K, Chen Q, Sagara Y, Schubert DJTJontojotSfN. The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death. 2001;21(16):6069-76. Ishige K, Chen Q, Sagara Y, Schubert DJTJontojotSfN. The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death. 2001;21(16):6069-76.
31.
go back to reference Jiang Y, Mao C, Yang R, Yan B, Shi Y, Liu X, et al. EGLN1/c-Myc induced lymphoid-specific helicase inhibits ferroptosis through lipid metabolic gene expression changes. 2017;7(13):3293-305. Jiang Y, Mao C, Yang R, Yan B, Shi Y, Liu X, et al. EGLN1/c-Myc induced lymphoid-specific helicase inhibits ferroptosis through lipid metabolic gene expression changes. 2017;7(13):3293-305.
32.
go back to reference Alim I, Caulfield J, Chen Y, Swarup V, Geschwind D, Ivanova E, et al. Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. 2019;177(5):1262-79.e25. Alim I, Caulfield J, Chen Y, Swarup V, Geschwind D, Ivanova E, et al. Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. 2019;177(5):1262-79.e25.
33.
go back to reference Gao M, Monian P, Pan Q, Zhang W, Xiang J. Jiang XJCr. Ferroptosis is an autophagic cell death process. 2016;26(9):1021–32. Gao M, Monian P, Pan Q, Zhang W, Xiang J. Jiang XJCr. Ferroptosis is an autophagic cell death process. 2016;26(9):1021–32.
34.
go back to reference Wu W, Papagiannakopoulos TJMc. The center cannot hold: NRF2 battles ferroptosis in the 3rd dimension. 2020;80(5):760-1. Wu W, Papagiannakopoulos TJMc. The center cannot hold: NRF2 battles ferroptosis in the 3rd dimension. 2020;80(5):760-1.
35.
go back to reference Stockwell B, Friedmann Angeli J, Bayir H, Bush A, Conrad M. Dixon S, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. 2017;171(2):273–85. Stockwell B, Friedmann Angeli J, Bayir H, Bush A, Conrad M. Dixon S, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. 2017;171(2):273–85.
36.
go back to reference Tang D. Kroemer GJSt, therapy t. Peroxisome: the new player in ferroptosis. 2020;5(1):273. Tang D. Kroemer GJSt, therapy t. Peroxisome: the new player in ferroptosis. 2020;5(1):273.
Metadata
Title
Identification of a ferroptosis-related gene signature predictive model in colon cancer
Authors
Ye Wang
Heng-bo Xia
Zhang-ming Chen
Lei Meng
A-man Xu
Publication date
01-12-2021
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2021
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-021-02244-z

Other articles of this Issue 1/2021

World Journal of Surgical Oncology 1/2021 Go to the issue